Avanos AVNS Q1 2026 Earnings Beat Revenue NA EPS 022 Cytosorbents CTSO Q1 2026 Results Miss Estimates EPS 008 vs 006 Medicus Pharma MDCX Q4 2025 Earnings Miss by Significant Key Takeaways Luang Prabangs UNESCO Status Under Threat as Mekong Dam Project Advances